Business
Currency:USD
2024/FY
Stock NameRevenueRatio
EXPAREL548.96M78.32%
ZILRETTA118.09M16.85%
iovera°22.81M3.25%
Bupivacaine liposome injectable suspension7.32M1.04%
Royalty revenue3.78M0.54%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
US, European Union (E.U.) and United Kingdom (UK)548.96M78.32%
United States118.09M16.85%
U.S., Canada and Europe22.81M3.25%
Bupivacaine liposome injectable suspension7.32M1.04%
Royalty revenue3.78M0.54%